Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yuko Miyata"'
Autor:
Yuko Miyata
Publikováno v:
Emerging Markets for Ecosystem Services: A Case Study of the Panama Canal Watershed ISBN: 9780367813413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::400fa909ef8b717618ded37cd6feace3
https://doi.org/10.1201/9780367813413-21
https://doi.org/10.1201/9780367813413-21
Autor:
Michelle Lichtenfels, Patrick Burtis, Alexander Hovani, Radha Kuppalli, Michael Lichtenfeld, Yuko Miyata
Publikováno v:
Emerging Markets for Ecosystem Services: A Case Study of the Panama Canal Watershed ISBN: 9780367813413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::335bfb1bdc669010a81e4990eafb96f2
https://doi.org/10.1201/9780367813413-24
https://doi.org/10.1201/9780367813413-24
Publikováno v:
Diabetes Therapy
Introduction Dipeptidyl peptidase-4 (DPP-4) inhibitors are an established treatment in type 2 diabetes mellitus (T2DM). The objective of this study was to investigate differences in quality of life (QOL) and treatment satisfaction among treatment-na
Autor:
Yousuke Kakitsubata, Yuko Miyata, Daphne J. Theodorou, Kousuke Marutsuka, Kazusada Shirao, Stavroula J. Theodorou
Publikováno v:
Journal of Clinical Ultrasound. 47:304-307
Macrocystic serous cystadenoma (MSC) of the pancreas is a rare benign neoplasm with varied imaging appearances. We describe an intriguing case of a surgically resected and histologically proven giant MSC, developed in the pararenal space. Ultrasonogr
Publikováno v:
Diabetes Therapy
Introduction Long-term glycemic control in type 2 diabetes is critical to prevent or delay the onset of macrovascular and microvascular complications. Medication adherence is an integral component of type 2 diabetes management. Minimizing the dosing
Autor:
Yuko Miyata, Daphne J. Theodorou, Yousuke Kakitsubata, Stavroula J Theodorou, Sachiko Kakitsubata
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 26(8)
Publikováno v:
Atherosclerosis. 292
Background and aims We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) after 8 weeks of omega-3 fatty acid ethyl esters (Omega-3) treatm
Autor:
Koki Nakamura, Emi Nakata, Kazuhiro Yamamoto, Kenkichi Sugiura, Yuko Miyata, Masunori Matsuzaki, Hiroyuki Tsutsui, Masafumi Yano
Publikováno v:
Journal of Cardiology. 61:267-274
Background Chronic heart failure (CHF) is an increasingly common cardiovascular disease despite recent advances in its diagnosis and management. Methods and results A multicenter, open-label study was designed to assess the efficacy and safety of 60-
Publikováno v:
Clinical Therapeutics. 34:838-848
Blood pressure is reported to be insufficiently controlled in50% of patients with hypertension. Guidelines for the management of hypertension recommend using drugs with different mechanisms of action when1 agent is needed to achieve the blood pressur
Autor:
Yuko Miyata, Kazuo Kubota, Akio Mimori, Yuko Takahashi, Ryogo Minamimoto, Miyako Morooka, Hiroyuki Yamashita, Kimiteru Ito
Publikováno v:
Annals of the New York Academy of Sciences. 1228:29-38
[(18) F]Fluorodeoxyglucose (FDG) is a tracer for glucose metabolism. Its distribution is not specific to cancer cells but is also observed in inflammatory tissue, including macrophages, capillaries, and fibroblasts. Rheumatoid arthritis (RA) is a sys